$24.94
0.240.97%
In chiusura: -
$22.51
-2.43-9.74%
After hour: May 29, 4:19 AM EDT
Roundhill GLP-1 & Weight Loss ETF (NASDAQ: OZEM)
Ticker | Name | Share % | |
---|---|---|---|
LLY | Eli Lilly & Co | 14.34% | |
CO | Novo Nordisk A/S ADR | 19.92% | |
JP | Chugai Pharmaceutical Co Ltd | 4.21% | |
AMGN | Amgen Inc. | 4.76% | |
HK | Innovent Biologics Inc | 3.84% | |
SM | Roche Holding Ag | 5.17% | |
LN | Developed Markets Astrazeneca Plc Sponsored Adr | 5.14% | |
KR | Hanmi Pharm Co Ltd | 2.71% | |
SH | Innovent Biologics Inc | 3.80% | |
PFE | Pfizer Inc | 3.41% | |
CORT | Corcept Therapeutics Inc | 2.77% | |
GPCR | Structure Therapeutics Inc | 4.39% | |
VKTX | Viking Therapeutics Inc Com | 4.33% | |
ALT | Altimmune Inc | 3.71% |
Quote.FAQ.Answers.ETFs.etf-performance
Quote.FAQ.Answers.ETFs.expense-ratio
Quote.FAQ.Answers.ETFs.aum
OZEM segue uno stile di investimento Large Cap Blend.
Le principali posizioni di OZEM includono: LLY (14.34%), CO (19.92%), JP (4.21%), AMGN (4.76%), HK (3.84%). Queste rappresentano le posizioni più grandi nel portafoglio dell'ETF.
I dati del volume medio giornaliero per OZEM non sono attualmente disponibili.